Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study Farhat Nasim20 April 2019 10:00 AM ISTThe drug, tanezumab, belongs to a new category of pain medications that target nerve growth factor, a protein involved in the growth of nerve cells,...